Relafen is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Advanced Rx Pharmacy Of Tennessee, Llc. The primary component is Nabumetone.
| Product ID | 80425-0052_b1fd7c72-ea6e-7a5e-e053-2995a90a4d01 |
| NDC | 80425-0052 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Relafen |
| Generic Name | Nabumetone 500mg |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2008-03-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA078671 |
| Labeler Name | Advanced Rx Pharmacy of Tennessee, LLC |
| Substance Name | NABUMETONE |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2008-03-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 73684-100 | RELAFEN | NABUMETONE |
| 73684-101 | RELAFEN | NABUMETONE |
| 80425-0052 | Relafen | Nabumetone 500mg |
| 80425-0053 | Relafen | Nabumetone 500mg |
| 80425-0054 | Relafen | Nabumetone 500mg |
| 80425-0104 | Relafen | Nabumetone 750mg |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RELAFEN 87702292 not registered Live/Pending |
Argent Development Group, LLC 2017-11-29 |
![]() RELAFEN 86251872 not registered Dead/Abandoned |
Argent Development Group, LLC 2014-04-14 |
![]() RELAFEN 73353073 1248125 Dead/Cancelled |
Beecham Inc. 1982-03-04 |